Rituximab with short duration chemotherapy followed by 90Y ibritumomab tiuxetan as first-line treatment for patients with follicular lymphoma: Update of a Minnie Pearl Cancer Research Network phase II trial

D. L. Shipley; F. A. Greco; D. R. Spigel; D. Edwards; M. Mayfield; K. Yost; J. P. Allerton; J. D. Hainsworth

doi:10.1200/jco.2005.23.16_suppl.6577

Rituximab with short duration chemotherapy followed by 90Y ibritumomab tiuxetan as first-line treatment for patients with follicular lymphoma: Update of a Minnie Pearl Cancer Research Network phase II trial

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.6577 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 6577-6577 ◽

Cited By ~ 22

Author(s):

D. L. Shipley ◽

F. A. Greco ◽

D. R. Spigel ◽

D. Edwards ◽

M. Mayfield ◽

...

Keyword(s):

Cancer Research ◽

Follicular Lymphoma ◽

Short Duration ◽

Phase Ii Trial ◽

Research Network ◽

Line Treatment ◽

First Line ◽

Ibritumomab Tiuxetan ◽

Cancer Research Network ◽

First Line Treatment

Download Full-text

Phase II trial of rituximab and short duration chemotherapy followed by 90Y-ibritumomab tiuxetan as first-line treatment for patients with follicular lymphoma: A Minnie Pearl Cancer Research Network phase II trial

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.6519 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 6519-6519 ◽

Cited By ~ 10

Author(s):

D. L. Shipley ◽

D. R. Spigel ◽

D. L. Carrell ◽

C. Dannaher ◽

F. A. Greco ◽

...

Keyword(s):

Cancer Research ◽

Follicular Lymphoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Research Network ◽

Line Treatment ◽

First Line ◽

Ibritumomab Tiuxetan ◽

Cancer Research Network ◽

First Line Treatment

Download Full-text

Phase II trial of rituximab and short duration chemotherapy followed by 90Y-ibritumomab tiuxetan as first-line treatment for patients with follicular lymphoma: A Minnie Pearl Cancer Research Network phase II trial

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.6519 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 6519-6519 ◽

Cited By ~ 2

Author(s):

D. L. Shipley ◽

D. R. Spigel ◽

D. L. Carrell ◽

C. Dannaher ◽

F. A. Greco ◽

...

Keyword(s):

Cancer Research ◽

Follicular Lymphoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Research Network ◽

Line Treatment ◽

First Line ◽

Ibritumomab Tiuxetan ◽

Cancer Research Network ◽

First Line Treatment

Download Full-text

Rituximab Plus Short-Duration Chemotherapy as First-Line Treatment for Follicular Non-Hodgkin's Lymphoma: A Phase II Trial of the Minnie Pearl Cancer Research Network

Yearbook of Oncology ◽

10.1016/s1040-1741(08)70138-6 ◽

2006 ◽

Vol 2006 ◽

pp. 194-196

Author(s):

M.S. Gordon

Keyword(s):

Cancer Research ◽

Short Duration ◽

Phase Ii ◽

Phase Ii Trial ◽

Hodgkin's Lymphoma ◽

Research Network ◽

Line Treatment ◽

First Line ◽

Cancer Research Network ◽

First Line Treatment

Download Full-text

First line treatment with weekly docetaxel, vinorelbine, and trastuzumab in HER2 overexpressing metastatic breast cancer (HER2+ MBC): A Minnie Pearl Cancer Research Network phase II trial

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.643 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 643-643 ◽

Cited By ~ 4

Author(s):

D. A. Yardley ◽

F. A. Greco ◽

L. L. Porter ◽

H. A. Burris ◽

C. Phelps ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Research ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Research Network ◽

Line Treatment ◽

First Line ◽

Cancer Research Network ◽

Weekly Docetaxel ◽

First Line Treatment

Download Full-text

Fludarabine/rituximab (FR) followed by alemtuzumab as first-line treatment for patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL): A Minnie Pearl Cancer Research Network phase II trial

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.6556 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 6556-6556 ◽

Cited By ~ 2

Author(s):

W. H. Liggett ◽

J. D. Hainsworth ◽

D. R. Spigel ◽

A. A. Meluch ◽

E. L. Raefsky ◽

...

Keyword(s):

Cancer Research ◽

Chronic Lymphocytic Leukemia ◽

Phase Ii Trial ◽

Lymphocytic Leukemia ◽

Research Network ◽

Line Treatment ◽

Small Lymphocytic Lymphoma ◽

First Line ◽

Cancer Research Network ◽

First Line Treatment

Download Full-text

First line treatment with weekly docetaxel, vinorelbine, and trastuzumab in HER2 overexpressing metastatic breast cancer (HER2+ MBC): A Minnie Pearl Cancer Research Network phase II trial

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.643 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 643-643 ◽

Cited By ~ 1

Author(s):

D. A. Yardley ◽

F. A. Greco ◽

L. L. Porter ◽

H. A. Burris ◽

C. Phelps ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Research ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Research Network ◽

Line Treatment ◽

First Line ◽

Cancer Research Network ◽

Weekly Docetaxel ◽

First Line Treatment

Download Full-text

Docetaxel and Epirubicin as First-Line Treatment for Patients with Metastatic Breast Cancer: A Minnie Pearl Cancer Research Network Phase II Trial

Cancer Investigation ◽

10.1080/07357900600814060 ◽

2006 ◽

Vol 24 (5) ◽

pp. 469-473 ◽

Cited By ~ 7

Author(s):

John D. Hainsworth ◽

Denise A. Yardley ◽

David R. Spigel ◽

Anthony A. Meluch ◽

David Rinaldi ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Research ◽

Metastatic Breast Cancer ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Research Network ◽

Line Treatment ◽

First Line ◽

Cancer Research Network ◽

First Line Treatment

Download Full-text

Irinotecan (I), carboplatin (C), and imatinib (IM) in the first-line treatment of extensive-stage small cell lung cancer (SCLC): A phase II trial of the Minnie Pearl Cancer Research Network

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.7049 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 7049-7049

Author(s):

D. S. Thompson ◽

J. D. Hainsworth ◽

D. R. Spigel ◽

M. A. Toomey ◽

M. S. Rubin ◽

...

Keyword(s):

Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Research Network ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Cancer Research Network ◽

Extensive Stage ◽

First Line Treatment

Download Full-text

Weekly Docetaxel and Bortezomib as First-Line Treatment for Patients with Hormone-Refractory Prostate Cancer: A Minnie Pearl Cancer Research Network Phase II Trial

Clinical Genitourinary Cancer ◽

10.3816/cgc.2007.n.004 ◽

2007 ◽

Vol 5 (4) ◽

pp. 278-283 ◽

Cited By ~ 28

Author(s):

John D. Hainsworth ◽

Anthony A. Meluch ◽

David R. Spigel ◽

John Barton ◽

Lisa Simons ◽

...

Keyword(s):

Prostate Cancer ◽

Phase Ii Trial ◽

Research Network ◽

Hormone Refractory Prostate Cancer ◽

Line Treatment ◽

First Line ◽

Cancer Research Network ◽

Weekly Docetaxel ◽

Hormone Refractory ◽

First Line Treatment

Download Full-text

Cancer Research Highlights: Rituximab's Value Shown in First-Line Treatment of Follicular Lymphoma

PsycEXTRA Dataset ◽

10.1037/e407462005-003 ◽

2005 ◽

Author(s):

Keyword(s):

Cancer Research ◽

Follicular Lymphoma ◽

Line Treatment ◽

First Line ◽

First Line Treatment

Download Full-text